• Bariatric surgery has been shown to significantly lower the risk of developing obesity-associated cancers, which are linked to metabolic dysregulation, chronic low-grade systemic inflammation, and hormonal alterations such as elevated insulin and sex hormone levels. The gene discussed is PLXNA3; the disease is obesity due to melanocortin 4 receptor deficiency.